NIH funding profile · San Mateo, CA · Company
Revagenix, Inc. NIH Funding
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
Revagenix, Inc. received $14.2M in NIH award funding in fiscal year 2026 across 2 award records and 2 principal investigators. That ranks #265 of 2,407 NIH-funded institutions and #31 in California.
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
FY2026 NIH funding
$14.2M
National rank
#265
0.04% of NIH extramural awards
Rank in California
#31
0.3% of California NIH funding
Awards · PIs
2
2 investigators · 0 new projects
NIH funding trend, FY2022–FY2026
Revagenix, Inc. received $48.7M in NIH awards over these five fiscal years. Annual funding moved +24.2% from FY2022 to FY2026. Its best national rank in the period was #245 (FY2024).
NIH institutes funding Revagenix, Inc., FY2026
1 NIH institutes and centers administered awards here in FY2026. The largest, the National Institute of Allergy and Infectious Diseases (NIAID), accounted for 100.0% of the institution's NIH funding across 2 awards.
- NIAID · National Institute of Allergy and Infectious Diseases$14.2M · 100.0%
2 awards · vs FY2025: —
Award mechanism mix
Share of NIH award dollars by activity-code family in FY2026, with the FY2022 share for comparison.
- Contracts (N)100.0% · FY22 100.0%
Top activity codes, FY2026
| Code | Awards | Funding | Share | Average award |
|---|---|---|---|---|
| N01 | 2 | $14.2M | 100.0% | $7.1M |
Largest FY2026 awards
The biggest single award records by FY2026 dollars. Each links to its NIH RePORTER project page.
- Development of Therapeutic Products for Antimicrobial Resistant (AMR) Infections and Emerging Infectious Diseases (opens NIH RePORTER)
75N93022C00061-P00008-9999-1 · NIAID
$12.1MN01
- Development of Therapeutic Products for Antibiotic Resistant Bacteria (opens NIH RePORTER)
75N93020C00018-P00021-9999-1 · NIAID
$2.1MN01
Other NIH-funded institutions in California
| # | Institution | Funding |
|---|---|---|
| 27 | The Lundquist InstituteTorrance, CA | $16.4M |
| 28 | SRI InternationalMenlo Park, CA | $16.0M |
| 29 | California Pacific Medical Center Research InstituteSan Francisco, CA | $15.7M |
| 30 | Loma Linda UniversityLoma Linda, CA | $15.3M |
| 31 | Revagenix, Inc.San Mateo, CA | $14.2M |
| 32 | Palo Alto Veterans Institute for ResearchPalo Alto, CA | $14.1M |
| 33 | Buck Institute for Research on AgingNovato, CA | $13.0M |
| 34 | Lighthouse Pharmaceuticals, Inc.Novato, CA | $12.6M |
| 35 | J. Craig Venter Institute, Inc.La Jolla, CA | $12.0M |
Nearby in the national ranking
| # | Institution | Funding |
|---|---|---|
| 262 | Translational Genomics Research InstitutePhoenix, AZ | $14.7M |
| 263 | Schepens Eye Research InstituteBoston, MA | $14.4M |
| 264 | Whitehead Institute for Biomedical ResearchCambridge, MA | $14.4M |
| 265 | Revagenix, Inc.San Mateo, CA | $14.2M |
| 266 | Palo Alto Veterans Institute for ResearchPalo Alto, CA | $14.1M |
| 267 | Arkansas Children's Research InstituteLittle Rock, AR | $13.9M |
| 268 | Versiti Blood Health, Inc.Milwaukee, WI | $13.4M |
Similar companies
| # | Institution | Funding |
|---|---|---|
| 242 | Dell Federal Systems L.P.Round Rock, TX | $18.1M |
| 248 | Cognition Therapeutics, Inc.Pittsburgh, PA | $16.5M |
| 253 | PsychoGenics, Inc.Paramus, NJ | $16.1M |
| 265 | Revagenix, Inc.San Mateo, CA | $14.2M |
| 274 | Advanced Bioscience Laboratories, Inc.Rockville, MD | $12.9M |
| 276 | Lighthouse Pharmaceuticals, Inc.Novato, CA | $12.6M |
| 280 | Precision Bioservices, Inc.Frederick, MD | $12.1M |
About these numbers
Source: the public NIH RePORTER API, refreshed October 16, 2026. See our data methodology and the guide to reading NIH funding rankings by university.
- Who is countedAwards made to NIH recipient organization code 10056405. A university's medical school, affiliated hospital, or other campuses can be separate NIH recipients with their own totals.
- What is countedTotal award amount (direct plus indirect) obligated in each fiscal year for grants, cooperative agreements, training awards, SBIR/STTR, and R&D contracts. Subprojects, intramural research, and interagency agreements are excluded.
- InstitutesEach award is credited in full to its administering institute, even when other institutes co-fund it.
- SubawardsNIH reports the prime recipient only, so research this institution performs under another organization's grant is not included here.